Dr. Raymond Kempf is a medical oncologist from Los Angeles, California. He has been in practice for more than 25 years. He graduated from the Harvard Medical School. Dr. Raymond Kempf is a board-certified specialist in internal medicine and medical oncology. He published several studies and managed to cover the following topics adjuvant immunotherapy for node-negative melanoma, skin carcinoma, and systemic therapy, metastatic renal cancer and cyclophosphamide and intravenous interleukin-2 doses. Dr. Kempf is currently affiliated with LAC - USC Medical Center.
Harvard Medical School
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the South...
Sondak, V.K., Liu, P., Tuthill, R.J., Kempf, R.A., Unger, J.M., Sosman, J.A., Thompson, J.A., Weiss, G.R., Redman, B.G., Jakowatz, J.G., Noyes, R.D., Flaherty, L.E.; J Clin Oncol. 2002 Apr 15.See more >>
Systemic therapy of skin carcinoma.
Kempf, R. A.; Cancer Treat Res. 1995.See more >>
Phase II study of low dose cyclophosphamide and intravenous interleukin-2 in metastatic renal cancer.
Quan, W. D., Dean, G. E., Lieskovsky, G., Mitchell, M. S., Kempf, R. A.; Invest New Drugs. 1994.See more >>